Using low-frequency radio waves to send blood pressure data, a group of students has provided a proof of concept that could enable in-home health care for people without cellular or broadband access.
A novel combination of artificial intelligence and production techniques could change the future of nanomedicine, according to Cornell researchers using a new $3 million grant from the National Science Foundation to revolutionize how polymer nanoparticles are manufactured.
Professor Oliver Gao’s Systems Architecture and Management program helps organizations understand the value of systems architecture related to performance, lifecycle cost, schedule and risk.
Eun-Ah Kim, professor of physics, and Google researchers report the first demonstration of two-dimensional particles, called non-Abelian anyons, that are the key ingredient for realizing topological quantum computing, a promising method of introducing fault resistance to quantum computing.
An interdisciplinary research team received a five-year, $2 million grant from the National Science Foundation to develop a new generation of biosynthetic lubricants that have the potential to treat arthritis and reduce the painful friction of artificial joints.
Mehrnaz Sabet, Mokshin Suri and Ruben Trujillo make up the latest cohort of the Cornell Engineering Commercialization Fellowship, a program that helps researchers evaluate their technology through a business lens.
An interdisciplinary team led by Cornell has received a five-year grant to launch a new center for engineering, testing and commercializing point-of-care diagnostic devices that will have international reach.
Materials scientists at Cornell have developed a method for better understanding the complex electrochemical reactions that occur at the interface of water and metal surfaces – an approach that will ultimately lead to better fuel cells and other electrochemical technologies.
Cornell researchers attached large fragments to temperamental "radical" molecules, increasing their girth to insulate them from their hyperreactive partners – a method that could help create improved derivatives of pharmaceutical compounds.